The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis
Open accessAbstract
UNLABELLED: PET with the glucose analog (18)F-FDG is increasingly used to monitor tumor response to therapy. To use quantitative measurements of tumor (18)F-FDG uptake for assessment of tumor response, the repeatability of this quantitative metabolic imaging method needs to be established. Therefore, we determined the repeatability of different standardized uptake value (SUV) measurements using the available data. METHODS: A systematic literature search was performed to identify studies addressing (18)F-FDG repeatability in malignant tumors. The level of agreement between test and retest values of 2 PET uptake measures, maximum SUV (SUV(max)) and mean SUV (SUV(mean)), was assessed with the coefficient of repeatability using generalized linear mixed-effects models. In addition, the influence of tumor volume on repeatability was assessed. Principal component transformation was used to compare the reproducibility of the 2 different uptake measures. RESULTS: Five cohorts were identified for this metaanalysis. For SUV(max) and SUV(mean), datasets of 86 and 102 patients, respectively, were available. Percentage repeatability is a function of the level of uptake. SUV(mean) had the best repeatability characteristics; for serial PET scans, a threshold of a combination of 20% as well as 1.2 SUV(mean) units was most appropriate. After adjusting for uptake rate, tumor volume had minimal influence on repeatability. CONCLUSION: SUV(mean) had better repeatability performance than SUV(max). Both measures showed poor repeatability for lesions with low (18)F-FDG uptake. We recommend the evaluation of biologic effects in PET by reporting a combination of minimal relative and absolute changes to account for test-retest variability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, lesion SUVs in [18F]FDG-PET show a test-retest variability in the same patient with the same PET scanner of up to 20% [189] and are usually even less comparable between different scanners and centers or under routine clinical conditions [190].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [189]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the common use of SUVmax in clinical practice, arising from its convenience, SUVpeak and SUVmean have been shown to be slightly less variable under test-retest conditions [189,191].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [189]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Self-citationFrom RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
Young, H. E., Baum, R. P., Cremerius, U., Herholz, K., Hoekstra, O. S., Lammertsma, A. A., Pruim, J., & Price, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00229-4 · Cited by 1,716
Self-citationJuweid, M., Stroobants, S., Hoekstra, O., Mottaghy, F., Dietlein, M., Guermazi, A., Wiseman, G., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,377
Self-citation(2004) · PubMed · Cited by 653
Self-citationInterpretation and Uses of Medical Statistics
Daly, L., & Bourke, G. J. (2000) · Wiley eBooks · doi:10.1002/9780470696750 · Cited by 559
Reproducibility of metabolic measurements in malignant tumors using FDG PET.
Weber, W., Ziegler, S. I., Thödtmann, R., Hanauske, A.-R., & Schwaiger, M. (1999) · PubMed · Cited by 390
Self-citationWesterterp, M., Pruim, J., Oyen, W. J. G., Hoekstra, O. S., Paans, A. M. J., Visser, E. P., van Lanschot, J. J. B., Sloof, G. W., & Boellaard, R. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0224-1 · Cited by 294
Self-citationKrak, N., Boellaard, R., Hoekstra, O., Twisk, J., Hoekstra, C., & Lammertsma, A. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1566-1 · Cited by 284
Self-citationMinn, H., Zasadny, K., Quint, L. E., & Wahl, R. (1995) · Radiology · doi:10.1148/radiology.196.1.7784562 · Cited by 280
Cited by
Sorted by citations
Barrington, S. F., Mikhaeel, N. G., Kostakoğlu, L., Meignan, M. A., Hutchings, M., Müeller, S., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,663
Self-citationLeijenaar, R. T. H., Carvalho, S., Velazquez, E. R., van Elmpt, W., Parmar, C., Hoekstra, O. S., Hoekstra, C. J., Boellaard, R., Dekker, A. L. A. J., Gillies, R. J., et al. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.812798 · Cited by 428
Self-citationvan Velden, F. H. P., Kramer, G. M., Frings, V., Nissen, I. A., Mulder, E. R., de Langen, A. J., Hoekstra, O. S., Smit, E. F., & Boellaard, R. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-0940-2 · Cited by 286
Self-citationStafford, W. C., Peng, X., Olofsson, M. H., Zhang, X., Luci, D. K., Lu, L., Cheng, Q., Tresaugues, L., Dexheimer, T. S., Coussens, N. P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7444 · Cited by 248
Repeatability of SUV in Oncologic 18F-FDG PET
Lodge, M. A. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.186353 · Cited by 214
Imaging for Staging and Response Assessment in Lymphoma
Johnson, S. A., Kumar, A. A., Matasar, M. J., Schöder, H. M., & Rademaker, J. (2015) · Radiology · doi:10.1148/radiol.2015142088 · Cited by 184
Quantitative imaging biomarkers: A review of statistical methods for computer algorithm comparisons
Obuchowski, N. A., Reeves, A. P., Huang, E. P., Wang, X., Buckler, A. J., Kim, G. H. J., Barnhart, H. X., Jackson, E. F., Giger, M. L., Pennello, G. A., et al. (2014) · Statistical Methods in Medical Research · doi:10.1177/0962280214537390 · Cited by 173
Pinker, K., Riedl, C. C., & Weber, W. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3687-3 · Cited by 172
Self-citationPace, L., Nicolai, E., Luongo, A., Aiello, M., Catalano, O. A., Soricelli, A., & Salvatore, M. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.11.002 · Cited by 129
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma
Paidpally, V., Chirindel, A., Lam, S., Agrawal, N., Quon, H., & Subramaniam, R. M. (2012) · Imaging in Medicine · doi:10.2217/iim.12.60 · Cited by 125
Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET
Karakatsanis, N. A., Zhou, Y., Lodge, M. A., Casey, M., Wahl, R. L., Zaidi, H., & Rahmim, A. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/22/8643 · Cited by 121
Tumor Quantification in Clinical Positron Emission Tomography
Bai, B., Bading, J. R., & Conti, P. S. (2013) · Theranostics · doi:10.7150/thno.5629 · Cited by 111
Clinical Utility of Quantitative Imaging
Rosenkrantz, A. B., Mendiratta‐Lala, M., Bartholmai, B. J., Ganeshan, D., Abramson, R. G., Burton, K. R., Yu, J. J., Scalzetti, E. M., Yankeelov, T. E., Subramaniam, R. M., et al. (2014) · Academic Radiology · doi:10.1016/j.acra.2014.08.011 · Cited by 108
PET/CT in Oncology: Current Status and Perspectives
Czernin, J. G., Allen-Auerbach, M., Nathanson, D. A., & Herrmann, K. (2013) · Current Radiology Reports · doi:10.1007/s40134-013-0016-x · Cited by 112
Metabolic Tumor Volume Metrics in Lymphoma
Kostakoğlu, L., & Chauvie, S. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.09.005 · Cited by 100
Weber, W., Gatsonis, C. A., Mozley, P. D., Hanna, L., Shields, A. F., Aberle, D. R., Govindan, R., Torigian, D. A., Karp, J. S., Yu, J. Q. (., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.147728 · Cited by 93
Self-citationThe QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy
Kinahan, P. E., Perlman, E. S., Sunderland, J. J., Subramaniam, R. M., Wollenweber, S. D., Turkington, T. G., Lodge, M. A., Boellaard, R., Obuchowski, N. A., & Wahl, R. L. (2020) · Radiology · doi:10.1148/radiol.2019191882 · Cited by 90
Self-citationPET/CT in nononcological lung diseases: current applications and future perspectives
Capitanio, S., Nordin, A. J., Noraini, A. R., & Rossetti, C. (2016) · European Respiratory Review · doi:10.1183/16000617.0051-2016 · Cited by 89
Zegers, C. M. L., van Elmpt, W., Szardenings, K., Kolb, H. C., Waxman, A., Subramaniam, R. M., Moon, D. H., Brunetti, J. C., Srinivas, S. M., Lambin, P., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3100-z · Cited by 72
Kramer, G. M., Frings, V., Hoetjes, N., Hoekstra, O. S., Smit, E. F., de Langen, A. J., & Boellaard, R. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.170225 · Cited by 65
Self-citationEvaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG
Chen, W.-J., Liu, L., Li, Y.-H., Li, S., Li, Z., Zhang, W.-G., Zhang, X., Wu, R., Hu, D., Sun, H.-Y., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05893-8 · Cited by 48
Combemale, P., Valeyrie‐Allanore, L., Giammarile, F., Pinson, S., Guillot, B., Mariano‐Goulart, D., Wolkenstein, P., Blay, J., & Mognetti, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085954 · Cited by 59
Fournier, L., de Geus-Oei, L. D., Regge, D., Oprea-Lager, D., D'Anastasi, M., Bidaut, L., Bäuerle, T., Lopci, E., Cappello, G., Lecouvet, F., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.800547 · Cited by 49
Carlier, T., & Bailly, C. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00018 · Cited by 54
Sindoni, A., Minutoli, F., Pontoriero, A., Iatì, G., Baldari, S., & Pergolizzi, S. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.03.019 · Cited by 53
Klaassen, R., Bennink, R. J., van Tienhoven, G., Bijlsma, M. F., Besselink, M. G., Henegouwen, M. I. V. B., Wilmink, J. W., Nederveen, A. J., Windhorst, A. D., Hulshof, M. C. C. M., et al. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.05.009 · Cited by 52
Pengel, K. E., Koolen, B. B., Loo, C. E., Vogel, W. V., Wesseling, J., Lips, E. H., Rutgers, E. J. T., Olmos, R. A. V., Peeters, M.-J. T. F. D. V., Rodenhuis, S., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2770-2 · Cited by 52
Whole-body magnetic resonance imaging in children: technique and clinical applications
Eutsler, E. P., & Khanna, G. (2016) · Pediatric Radiology · doi:10.1007/s00247-016-3586-y · Cited by 52
Influences on PET Quantification and Interpretation
Rogasch, J. M. M., Hofheinz, F., van Heek, L., Voltin, C.-A., Boellaard, R., & Kobe, C. (2022) · Diagnostics · doi:10.3390/diagnostics12020451 · Cited by 57
Self-citationHuang, E. P., Wang, X. F., Choudhury, K. R., McShane, L. M., Gönen, M., Ye, J., Buckler, A. J., Kinahan, P. E., Reeves, A. P., Jackson, E. F., et al. (2014) · Statistical Methods in Medical Research · doi:10.1177/0962280214537394 · Cited by 51
Abdülrezzak, Ü., Kurt, Y. K., Kula, M., & Tutuş, A. (2016) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000522 · Cited by 48
Li, X., Rowe, S. P., Leal, J. P., Gorin, M. A., Allaf, M. E., Ross, A. E., Pienta, K. J., Lodge, M. A., & Pomper, M. G. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.179739 · Cited by 48
Performance of Digital PET Compared with High-Resolution Conventional PET in Patients with Cancer
Koopman, D., van Dalen, J. A., Stevens, H., Slump, C. H., Knollema, S., & Jager, P. L. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.238105 · Cited by 49
Trigonis, I., Koh, P. K., Taylor, B., Tamal, M., Ryder, W. D. J., Earl, M., Anton‐Rodriguez, J., Haslett, K., Young, H. E., Finn, C. F., et al. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2632-3 · Cited by 47
Reinert, C. P., Schuhmann, M. U., Bender, B., Gugel, I., la Fougère, C. J., Schäfer, J. F., & Gatidis, S. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4227-5 · Cited by 47
van Sluis, J., van Snick, J. H., Brouwers, A. H., Noordzij, W., Dierckx, R. A. J. O., Borra, R., Lammertsma, A. A., Glaudemans, A. W. J. M., Slart, R. H. J. A., Yaqub, M. M., et al. (2022) · EJNMMI Physics · doi:10.1186/s40658-022-00504-9 · Cited by 46
Self-citationBelhocine, T., Blankenberg, F. G., Kartachova, M. S., Stitt, L., Vanderheyden, J., Hoebers, F. J. P., & de Wiele, C. V. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3152-0 · Cited by 44
Lambrecht, M., Melidis, C., Sonke, J., Adebahr, S., Boellaard, R., Verheij, M., Gückenberger, M., Nestle, U., & Hurkmans, C. (2016) · Radiation Oncology · doi:10.1186/s13014-015-0567-5 · Cited by 41
Self-citationRockall, A., Avril, N. E., Lam, R., Iannone, R., Mozley, P. D., Parkinson, C., Bergstrom, D., Sala, E., Sarker, S., McNeish, I. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2634 · Cited by 40
PET/CT in Radiotherapy Planning for Head and Neck Cancer
Newbold, K. L., & Powell, C. J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00189 · Cited by 39
Rasmussen, J. H., Fischer, B. M., Aznar, M. C., Hansen, A. E., Vogelius, I. R., Löfgren, J., Andersen, F. L., Loft, A., Kjær, A., Højgaard, L., et al. (2015) · British Journal of Radiology · doi:10.1259/bjr.20140655 · Cited by 39
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls
Cho, S. Y., Huff, D. T., Jeraj, R., & Albertini, M. R. (2020) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.06.001 · Cited by 37
Application of PET Tracers in Molecular Imaging for Breast Cancer
Boers, J., de Vries, E. F. J., Glaudemans, A. W. J. M., Hospers, G. A. P., & Schroder, C. P. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00940-9 · Cited by 37
Kurland, B. F., Peterson, L. M., Shields, A. T., Lee, J. H., Byrd, D. W., Novakova-Jiresova, A., Muzi, M., Specht, J. M., Mankoff, D. A., Linden, H. M., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.209544 · Cited by 36
Burger, I. A., Vargas, H. A., Apte, A., Beattie, B. J., Humm, J. L., Gönen, M., Larson, S. M., & Schmidtlein, C. R. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.02.006 · Cited by 35
Wangaryattawanich, P., Branstetter, B. F., Hughes, M. A., Clump, D. A., Heron, D. E., & Rath, T. J. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5767 · Cited by 34
Hartung-Knemeyer, V., Beiderwellen, K. J., Buchbender, C., Kuehl, H., Lauenstein, T. C., Bockisch, A., & Poeppel, T. D. (2013) · Investigative Radiology · doi:10.1097/rli.0b013e3182823695 · Cited by 33
Schmall, J. P., Surti, S., Otero, H. J., Servaes, S. E., Karp, J. S., & States, L. J. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.240127 · Cited by 33
Use of population input functions for reduced scan duration whole-body Patlak 18F-FDG PET imaging
van Sluis, J., Yaqub, M. M., Brouwers, A. H., Dierckx, R., Noordzij, W., & Boellaard, R. (2021) · EJNMMI Physics · doi:10.1186/s40658-021-00357-8 · Cited by 32
Self-citationSUV variability in EARL-accredited conventional and digital PET
Koopman, D., Jager, P. L., Slump, C. H., Knollema, S., & van Dalen, J. A. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0569-7 · Cited by 31
Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak
Laffon, É., Lamare, F., de Clermont-Gallerande, H., Burger, I. A., & Marthan, R. (2014) · European Radiology · doi:10.1007/s00330-014-3222-x · Cited by 29
Boellaard, R. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3182-7 · Cited by 28
Self-citationRepeatability of Gallium-68 DOTATOC Positron Emission Tomographic Imaging in Neuroendocrine Tumors
Menda, Y., Ponto, L. L. B., Schultz, M. K., Zamba, G. K. D., Watkins, G. L., Bushnell, D. L., Madsen, M. T., Sunderland, J. J., Graham, M. M., O’Dorisio, T. M., et al. (2013) · Pancreas · doi:10.1097/mpa.0b013e318287ce21 · Cited by 29
Doot, R. K., McDonald, E. S., & Mankoff, D. A. (2014) · Clinical and Translational Imaging · doi:10.1007/s40336-014-0071-1 · Cited by 27
Artificial intelligence guided enhancement of digital PET: scans as fast as CT?
Hosch, R., Weber, M., Sraieb, M., Flaschel, N., Haubold, J., Kim, M. S., Umutlu, L., Kleesiek, J., Herrmann, K., Nensa, F., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05901-x · Cited by 27
Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance
Wehrenberg-Klee, E. P., Turker, N. S., Heidari, P., Larimer, B. M., Juric, D., Baselga, J. M., Scaltriti, M., & Mahmood, U. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.169417 · Cited by 27
Sjövall, J., Chua, B., Pryor, D. I., Burmeister, E. A., Foote, M. C., Panizza, B. J., Burmeister, B. H., & Porceddu, S. V. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.12.009 · Cited by 26
Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma
Saadani, H., van der Hiel, B., Aalbersberg, E. A., Zavrakidis, I., Haanen, J. B. A. G., Hoekstra, O. S., Boellaard, R., & Stokkel, M. P. M. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.228312 · Cited by 26
Self-citationHeijmen, L., de Geus‐Oei, L., de Wilt, J. H. W., Visvikis, D., Hatt, M., Visser, E. P., Bussink, J., Punt, C. J. A., Oyen, W. J. G., & van Laarhoven, H. W. M. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2233-6 · Cited by 26
Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer
Oprea‐Lager, D. E., Kramer, G. M., van de Ven, P. M., van den Eertwegh, A. J. M., van Moorselaar, R. J. A., Schober, P. R., Hoekstra, O. S., Lammertsma, A. A., & Boellaard, R. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.167692 · Cited by 25
Self-citationThyroid lesions incidentally detected by 18 F-FDG PET-CT ― a two centre retrospective study
Jamšek, J., Žagar, I., Gaberšček, S., & Grmek, M. (2014) · Radiology and Oncology · doi:10.2478/raon-2014-0039 · Cited by 23
Fowler, K. J., McConathy, J., & Narra, V. R. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24308 · Cited by 23
Letellier, A., Johnson, A. C., Kit, N. H., Savigny, J.-F., Batalla, A., Parienti, J., & Aide, N. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1132-4 · Cited by 23
Costa, P. F., Jentzen, W., Brahmer, A., Mavroeidi, I. A., Zarrad, F., Umutlu, L., Fendler, W. P., Rischpler, C., Herrmann, K., Conti, M., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09993-4 · Cited by 22
The role of functional imaging in the era of targeted therapy of renal cell carcinoma
Braunagel, M., Graser, A., Reiser, M. F., & Notohamiprodjo, M. (2013) · World Journal of Urology · doi:10.1007/s00345-013-1074-7 · Cited by 22
Aryal, M. P., Nagaraja, T. N., Brown, S. L., Lü, M., Bagher‐Ebadian, H., Ding, G., Panda, S., Keenan, K. A., Cabral, G., Mikkelsen, T., et al. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3178 · Cited by 21
Crandall, J. P., Gajwani, P., Joo Hyun, O., Mawhinney, D. D., Sterzer, F., & Wahl, R. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214765 · Cited by 21
Ohlendorf, F., Henkenberens, C., Brunkhorst, T., Roß, T. L., Christiansen, H., Bengel, F. M., & Derlin, T. (2022) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.20.03238-0 · Cited by 20
Aide, N., Fauchille, P., Coquan, E., Ferron, G., Combe, P., Meunier, J., Alexandre, J., Berton, D., Leary, A. F., Rauglaudre, G. D., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05092-3 · Cited by 19
Wang, D., Zhang, M., Gao, X., & Yu, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158307 · Cited by 20
Impact of PET reconstruction algorithm and threshold on dose painting of non-small cell lung cancer
Knudtsen, I. S., van Elmpt, W., Öllers, M., & Malinen, E. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.09.012 · Cited by 18
Hong, I. K., Lee, J., Hwang, I. K., Paik, S. S., Kim, C., & Lee, S. H. (2020) · Cancer Management and Research · doi:10.2147/cmar.s259055 · Cited by 18
Olin, A. B., Ladefoged, C. N., Langer, N. H., Keller, S. H., Löfgren, J., Hansen, A. E., Kjær, A., Langer, S. W., Fischer, B. M., & Andersen, F. L. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.198853 · Cited by 17
Rasmussen, J. H., Vogelius, I. R., Aznar, M. C., Fischer, B. M., Christensen, C. B., Friborg, J., Loft, A., Kristensen, C. A., Bentzen, S. M., & Specht, L. (2015) · Acta Oncologica · doi:10.3109/0284186x.2015.1061694 · Cited by 16
SUV Harmonization Between Different Hybrid PET/CT Systems
Rubello, D., & Colletti, P. M. (2018) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002284 · Cited by 16
Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT
Groshar, D., Bernstine, H., Goldberg, N., Nidam, M., Stein, D. J., Abadi‐Korek, I., & Domachevsky, L. (2017) · Cancer Imaging · doi:10.1186/s40644-017-0113-9 · Cited by 15
Costa, P. F., Jentzen, W., Süßelbeck, F., Fendler, W. P., Rischpler, C., Herrmann, K., Conti, M., Kersting, D., & Weber, M. (2021) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.21.03300-8 · Cited by 15
Software-based PET-MR image coregistration: combined PET-MRI for the rest of us!
Robertson, M. S., Liu, X., Plishker, W. L., Zaki, G., Vyas, P. K., Safdar, N. M., & Shekhar, R. (2016) · Pediatric Radiology · doi:10.1007/s00247-016-3641-8 · Cited by 15
Ferretti, A., Chondrogiannis, S., Rampin, L., Bellan, E., Marzola, M. C., Grassetto, G., Gusella, S., Maffione, A. M., Gava, M. M., & Rubello, D. (2018) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aaee27 · Cited by 15
Monsef, A., Ay, M., Sheikhzadeh, P., Geramifar, P., Rahmim, A., & Ghafarian, P. (2022) · Nuclear medicine communications · doi:10.1097/mnm.0000000000001598 · Cited by 11
Quantitative differences in [(18)F] NaF PET/CT: TOF versus non-TOF measurements.
Oldan, J. D., Turkington, T. G., Choudhury, K. R., & Chin, B. B. (2015) · Europe PMC (PubMed Central) · Cited by 14
Roef, M., Rijnsdorp, S., Brouwer, C., Wyndaele, D., & Arends, A. (2021) · Diagnostics · doi:10.3390/diagnostics11061100 · Cited by 11
A risk management approach for imaging biomarker-driven clinical trials in oncology
Liu, Y., deSouza, N. M., Shankar, L. K., Kauczor, H., Trattnig, S., Collette, S., & Chiti, A. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00164-3 · Cited by 13
Self-citationDuan, C., Chaovalitwongse, W. A., Bai, F., Hippe, D. S., Wang, S., Thammasorn, P., Pierce, L. A., Liu, X., You, J., Miyaoka, R. S., et al. (2020) · Physics in Medicine and Biology · doi:10.1088/1361-6560/abb0c7 · Cited by 13
Ricard, F., Barrington, S., Korn, R., Brueggenwerth, G., Trotman, J., Cheson, B., Salles, G., Schwartz, L., Goldmacher, G., Jarecha, R., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264124 · Cited by 12
Kurland, B. F., Doot, R. K., Linden, H. M., Mankoff, D. A., & Kinahan, P. E. (2013) · Clinical Trials · doi:10.1177/1740774513506618 · Cited by 12
Variability of Total Lesion Glycolysis by 18F-FDG-Positive Tissue Thresholding in Lung Cancer
Laffon, É., de Clermont-Gallerande, H., Lamare, F., & Marthan, R. (2013) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.113.122952 · Cited by 12
Wangaryattawanich, P., Branstetter, B. F., Ly, J. D., Duvvuri, U., Heron, D. E., & Rath, T. J. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6589 · Cited by 12
Shankar, L. K., Huang, E. P., Litière, S., Hoekstra, O. S., Schwartz, L. H., Collette, S., Boellaard, R., Bogaerts, J., Seymour, L., & de Vries, E. G. E. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3143 · Cited by 11
Self-citationKramer, G. M., Liu, Y., Langen, A. J. D., Jansma, E. P., Trigonis, I., Asselin, M., Jackson, A., Kenny, L. M., Aboagye, E. O., Hoekstra, O. S., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3923-x · Cited by 11
Self-citationClinical evaluation of respiration-induced attenuation uncertainties in pulmonary 3D PET/CT
Kruis, M. F., van de Kamer, J. B., Vogel, W. V., Belderbos, J. S. A., Sonke, J., & van Herk, M. (2015) · EJNMMI Physics · doi:10.1186/s40658-014-0107-7 · Cited by 11
Two-Time-Point FDG PET/CT: Liver SULmean Repeatability
Tahari, A. K., Paidpally, V., Chirindel, A., Wahl, R. L., & Subramaniam, R. M. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.12719 · Cited by 10
Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trials
Doot, R. K., Thompson, T., Greer, B. E., Allberg, K. C., Linden, H. M., Mankoff, D. A., & Kinahan, P. E. (2012) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2012.06.002 · Cited by 10
Mathieu, C., Ferrer, L., Carlier, T., Colombié, M., Rusu, D., Kraeber‐Bodéré, F., Campion, L., & Rousseau, C. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00067 · Cited by 10
Repeatability of Quantitative 18F-FET PET in Glioblastoma
Ferjančič, P., Ebert, M. A., Francis, R. J., Nowak, A. K., & Jeraj, R. (2021) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/abfae9 · Cited by 10
Odewole, O. A., Oyenuga, O. A., Tade, F. I., Savir-Baruch, B., Nieh, P. T., Master, V. A., Chen, Z., Wang, X., Jani, A. B., Bellamy, L. M., et al. (2014) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0797-1 · Cited by 9
Preclinical Evaluation of 89Zr-Panitumumab for Biology-Guided Radiation Therapy
Natarajan, A., Khan, S., Liang, X., Nguyen, H. T. M., Das, N., Anders, D., Malik, N., Oderinde, O. M., Chin, F. T., Rosenthal, E. L., et al. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.01.007 · Cited by 9
Wyatt, J., Kaushik, S. S., Cozzini, C., Pearson, R., Petrides, G. S., Wiesinger, F., McCallum, H. M., & Maxwell, R. J. (2024) · EJNMMI Physics · doi:10.1186/s40658-024-00617-3 · Cited by 9
Sugita, S., Yamato, M., Hatabu, T., & Kataoka, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-88414-1 · Cited by 9
PET/CT in therapy evaluation of patients with lung cancer
Langer, N. H., Christensen, T. N., Langer, S. W., Kjær, A., & Fischer, B. M. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.883280 · Cited by 9
Metadata
- Authors
- de Langen, A. J., Vincent, A., Velasquez, L. M., van Tinteren, H., Boellaard, R., Shankar, L. K., Boers, M., Smit, E. F., Stroobants, S., Weber, W. A., & Hoekstra, O. S.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- The Netherlands Cancer Institute (NL)
- Bristol-Myers Squibb (United States) (US)
- National Cancer Institute (US)
- Antwerp University Hospital (BE)
- University of Freiburg (DE)
- Corresponding author
- de Langen, Adrianus J.
- ORCID
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2012-04-10
- Volume
- 53
- Issue
- 5
- Pages
- 701-708
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2149015860
- Cited by
- 157
- References
- 31
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 13 · 2021: 7 · 2020: 14 · 2019: 5 · 2018: 9 · 2017: 13 · 2016: 17 · 2015: 22 · 2014: 21 · 2013: 14 · 2012: 5
- FWCI
- 14.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Nuclear Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Keywords
- 18F-FDG PET, standardized uptake value, SUVmax, SUVmean, test-retest repeatability, tumor response assessment, tumor volume, uptake rate, cancer
- MeSH terms
- Biological Transport, Humans, Neoplasms, Reproducibility of Results, Fluorodeoxyglucose F18, Tumor Burden, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
